CircRNAs are thus becoming more clinically relevant in breast cancer diagnosis, particularly for their early detection and stratification into different subtypes; which ameliorates the disease prognosis; however, they have been poorly explored in HER2-related BC subtypes, and more investigations are needed. This evidence concerns the gene ERBB2 and breast carcinoma.